WCPS: Analytical Workflow for Elemental Extractables and Leachables in reference to USP and ICH Guidelines: Intravenous Bag Case Study
Posters | 2017 | Agilent TechnologiesInstrumentation
Elemental extractables and leachables from pharmaceutical packaging can compromise drug safety by introducing trace metal contaminants into formulations. Intravenous bags, which directly contact parenteral solutions, present a critical case for screening elemental impurities to ensure compliance with regulatory exposure limits and protect patient health.
This case study establishes a comprehensive workflow for profiling 70 elemental impurities in IV bag materials according to United States Pharmacopeia (USP) and International Council for Harmonization (ICH) guidelines. The goals include optimizing extraction conditions, analytical instrumentation, and data processing to deliver accurate, reliable quantitation across trace and major element ranges.
Extraction Protocol
The IV bag components (bag film, tubing, filter) were separately subjected to aqueous and saline extractions at 50 °C with 50 rpm shaking for 72 hours to simulate worst-case leaching conditions.
Standards and Quality Control
Data Acquisition and Analysis
MassHunter automated the ICP-MS setup, autotune, and USP-ICH method execution. Results were imported into Agilent Mass Profiler Professional for statistical evaluation, including principal component analysis to compare solvent effects.
All 70 elements were detected within regulatory limits, confirming method sensitivity and dynamic range. However, over ten toxic metals—including arsenic, cadmium, mercury, lead, cobalt, nickel, chromium, molybdenum, antimony, and barium—migrated into extraction solvents at trace levels. Multivariate analysis revealed distinct elemental profiles between saline and water extracts, with zinc notably elevated in saline, underscoring matrix-dependent leaching behavior.
Advancements in high-throughput ICP-MS, coupled with data-driven software and AI-enhanced analytics, will further streamline E&L testing. Emerging packaging materials and stricter regulatory thresholds will drive method innovations, while integration with orthogonal techniques such as time-of-flight MS may offer broader contaminant coverage.
This study demonstrates a robust, reproducible workflow for profiling elemental extractables and leachables in IV bags, meeting USP-ICH requirements and providing critical safety data. The approach supports risk assessment and quality assurance in pharmaceutical packaging.
ICP/MS
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Summary
Significance of the Topic
Elemental extractables and leachables from pharmaceutical packaging can compromise drug safety by introducing trace metal contaminants into formulations. Intravenous bags, which directly contact parenteral solutions, present a critical case for screening elemental impurities to ensure compliance with regulatory exposure limits and protect patient health.
Objectives and Study Overview
This case study establishes a comprehensive workflow for profiling 70 elemental impurities in IV bag materials according to United States Pharmacopeia (USP) and International Council for Harmonization (ICH) guidelines. The goals include optimizing extraction conditions, analytical instrumentation, and data processing to deliver accurate, reliable quantitation across trace and major element ranges.
Instrumentation
- Agilent 7800 ICP-MS with Ultra High Matrix Introduction (UHMI) system to tolerate up to 25% total dissolved solids.
- Octopole Reaction System in helium mode to reduce common polyatomic interferences.
- Agilent MassHunter software featuring automated USP-ICH preset methods and Excel interfacing for streamlined data handling.
Methodology
Extraction Protocol
The IV bag components (bag film, tubing, filter) were separately subjected to aqueous and saline extractions at 50 °C with 50 rpm shaking for 72 hours to simulate worst-case leaching conditions.
Standards and Quality Control
- Prepared calibration stocks for 70 elements in 5% nitric acid, covering 0.1–10 ppb with extensions to 100–1000 ppb for high-abundance species like sodium.
- Employed independently sourced QC standards at 0.5 and 5 ng/g and sample spikes at 0.1 and 1 µg/kg to validate accuracy and precision.
- Diluted extracts 1:10 in 5% nitric acid and analyzed each sample in triplicate.
Data Acquisition and Analysis
MassHunter automated the ICP-MS setup, autotune, and USP-ICH method execution. Results were imported into Agilent Mass Profiler Professional for statistical evaluation, including principal component analysis to compare solvent effects.
Key Results and Discussion
All 70 elements were detected within regulatory limits, confirming method sensitivity and dynamic range. However, over ten toxic metals—including arsenic, cadmium, mercury, lead, cobalt, nickel, chromium, molybdenum, antimony, and barium—migrated into extraction solvents at trace levels. Multivariate analysis revealed distinct elemental profiles between saline and water extracts, with zinc notably elevated in saline, underscoring matrix-dependent leaching behavior.
Practical Implications and Benefits
- A single-run ICP-MS approach accelerates sample throughput by combining trace and major element detection over ten orders of magnitude.
- UHMI and helium-mode collision cell technologies ensure robust performance in high-salt matrices.
- Automated software workflows reduce development time and support compliance with USP and ICH validation criteria.
Future Trends and Opportunities
Advancements in high-throughput ICP-MS, coupled with data-driven software and AI-enhanced analytics, will further streamline E&L testing. Emerging packaging materials and stricter regulatory thresholds will drive method innovations, while integration with orthogonal techniques such as time-of-flight MS may offer broader contaminant coverage.
Conclusion
This study demonstrates a robust, reproducible workflow for profiling elemental extractables and leachables in IV bags, meeting USP-ICH requirements and providing critical safety data. The approach supports risk assessment and quality assurance in pharmaceutical packaging.
References
- Solomon P. E., Nelson J., Jordi M. Analytical Workflow for Elemental Extractables and Leachables in Reference to USP and ICH Guidelines: Intravenous Bag Case Study. Poster #73, EWCPS 2017.
- Khera S., Jordi M., Arnaud C. Analysis of Extractables and Leachables: Methodologies, Regulations, Best Practices Series. Chemical & Engineering News, 2016.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Determination of Extractable and Leachable Elements Using ICP-MS
2022|Agilent Technologies|Applications
Application Note Pharmaceuticals Determination of Extractable and Leachable Elements Using ICP-MS Analysis of elemental impurities from plastic ophthalmic drug containers using an Agilent 7900 ICP-MS Authors Paige Solomon University of California, San Francisco, CA, USA Jenny Nelson Agilent Technologies, Inc.…
Key words
loq, loqophthalmic, ophthalmiceye, eyedrug, drugelemental, elementalcontainer, containerleachable, leachableproduct, productdrops, dropsleachables, leachablesextractables, extractablessonicated, sonicatedimpurities, impuritiesandbiologics, andbiologicselements
Extractables Analysis of Elements in Plastic Pharmaceutical Packaging
2023|Shimadzu|Applications
Inductively Coupled Plasma Mass Spectrometer Application News ICPMS-2030 Extractables Analysis of Elements in Plastic Pharmaceutical Packaging Chiho Kiriyama, Aya Urushizaki, Tadashi Taniguchi, and Takahide Hiramatsu User Benefits Extracted elements can be examined based on extractables and leachables (E&L) guidelines.…
Key words
extractables, extractablesextraction, extractionelement, elementextracted, extractedleachables, leachablesspike, spikeelemental, elementalnews, newssolvent, solventpvc, pvcrecovery, recoveryeva, evapackaging, packagingelements, elementsfrom
USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution
2021|Agilent Technologies|Technical notes
White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. Potentially toxic and harmful contaminants—including elemental impurities—must…
Key words
icp, icpelemental, elementalich, ichagilent, agilentpde, pdeusp, uspelements, elementslimits, limitspharmaceutical, pharmaceuticaldilution, dilutionimpurities, impuritiesmasshunter, masshunterdrug, drugdaily, dailysoftware
ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS
2017|Agilent Technologies|Others
ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS ICP-MS Addressing the new ICH and USP methods for measuring elemental impurities in pharmaceutical materials New methods for determining elemental impurities must be implemented by the pharmaceutical industry Control of impurities, including elemental (inorganic) contaminants,…
Key words
istd, istdelemental, elementalconc, concppb, ppbpde, pderatio, ratioicp, icpimpurities, impuritiespharmaceutical, pharmaceuticalpharmaceuticals, pharmaceuticalsnew, newree, reeharmonisation, harmonisationmethods, methodslimits